Peptika.
Cat. 02
Type I · Lyophilised
PK-2026-EPITHA
Peptika Epithalon vial
Lot-tracedEU pharmacyCold-chain 2–8 °C
02 · Longevity & Anti-aging

Epithalon.

Tetrapeptide derived from epithalamin — telomerase activity and circadian alignment.

Select strengthPer-vial price
Quantity
1
Total
€60.00· 1 vial

Build your bag, then either book a consultation (an EU-licensed physician reviews your file — anything declined is refunded) or upload an existing Rx at checkout.

  • Magistral preparation — Directive 2001/83/EC Art. 5(1).
  • Patient-named prescription only — dispensed against a valid Rx.
  • EU-GMP Annex 1 Grade A/B cleanroom compounding.
  • Cold-chain shipping across EU/EEA — 2–5 working days.
Overview

About Epithalon.

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a pineal-gland extract studied since the 1980s by Vladimir Khavinson and colleagues. It has been studied for effects on circadian regulation, immune function and telomere maintenance.

Most of the human data comes from Russian and East-European geriatric cohorts. The mechanistic claim of telomerase activation has been demonstrated in vitro; the long-term clinical implications remain under investigation.

Mechanism of action

Epithalon binds DNA at specific telomeric and promoter regions, modulating gene expression. In vitro it activates telomerase reverse transcriptase (TERT), extending telomere length in cultured human cells. In vivo it appears to restore physiological melatonin and cortisol rhythms in older adults.

Posology · for information only

Subcutaneous injection, typically 5–10 mg per day for 10–20 day courses, repeated 1–2 times per year.

Your physician sets the prescription. This is descriptive information, not a self-administration guide.

Storage

Lyophilised: store at 2–8 °C, protect from light. Once reconstituted: 2–8 °C, use within 30 days. Do not freeze.

Evidence baseClinical case-series evidence
Indications studied
Telomere maintenanceCircadian regulationGeroprotection
Identification & specifications
INN / Name
Epithalon
Form
Lyophilised vial · subcutaneous injection
Strength
50mg vial
Manufacturing
EU-GMP Annex 1 · Grade A/B
Endotoxins
European Pharmacopoeia 2.6.14 · LAL assay
Identity & purity
HPLC + MS · > 98%
Cold chain
Validated 2–8 °C, monitored end-to-end
Regulatory basis
Directive 2001/83/EC · Article 5(1)
Logistics

2–5 working days

EU / EEA cold-chain delivery, 2–8 °C monitored end-to-end with digital temperature log. Tracking link sent on dispatch.

Legal status

Magistral preparation

Patient-named preparation under Directive 2001/83/EC Article 5(1). Dispensed exclusively against a valid EU prescription.

Cross-border

EU prescription recognition

Prescriptions written in one EU member state are recognised in others under Directive 2011/24/EU on cross-border healthcare.